1st Surgery Department, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
Case Report
Metabolic-Associated Fatty Liver Disease - A Silent or an Aggressive Killer? A Case Report
Author(s): Oana-Bogdana Bărboi, Vasile-Liviu Drug*, Alina Pleșa, Diana-Elena Iov, Radu-Alexandru Vulpoi, Ludmila Știrbu, Mariana Floria and Irina Ciortescu
The rising incidence of hepatocellular carcinoma (HCC) in non-cirrhotic patients in recent years implies the presence of other factors that could
contribute to liver carcinogenesis. Metabolic-associated fatty liver disease (MAFLD) can progress to HCC, which poses a significant burden on the
healthcare systems worldwide and has a high mortality rate. An aggressive non-invasive surveillance strategy is necessary in order to detect liver
cancer in non-cirrhotic patients, especially in those with risk factors such as diabetes, obesity or older age. An acute clinical presentation is possible
through complications, such as the development of hemoperitoneum due to the non-traumatic HCC rupture... Read More»
DOI:
10.37421/2165-7920.2023.13.1551
Journal of Clinical Case Reports received 1295 citations as per Google Scholar report